Estrogen regulation of the cytochrome P450 3A subfamily in humans

被引:43
|
作者
Williams, ET
Leyk, M
Wrighton, SA
Davies, PJA
Loose, DS
Shipley, GL
Strobel, HW
机构
[1] Univ Texas, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, Houston, TX USA
[2] Univ Texas, Hlth Sci Ctr, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX USA
[3] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA
[4] Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA
关键词
D O I
10.1124/jpet.104.068908
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study examines the possible role of estrogen in regulating the expression of the human CYP3A subfamily: CYP3A4, CYP3A5, CYP3A7, and CYP3A43. To accomplish this goal, mRNA was quantified from human livers and endometrial samples, and total CYP3A protein levels were evaluated by Western immunoblot analysis of the liver samples. The human endometrial samples were from premenopausal and postmenopausal women. The premenopausal endometrium was either in the proliferative or secretory phase, whereas for the postmenopausal endometrium samples, the women had been treated with either a placebo or estropipate, an estrogen substitute. After analyses, CYP3A4 mRNA was shown to have lower hepatic expression in females than in males. In the endometrium, CYP3A4 and CYP3A43 are down-regulated by estrogen, whereas CYP3A5 is expressed at higher levels during the secretory phase. CYP3A7 was not detected in the endometrium. In addition, the CYP3A subfamily showed increased mRNA expression in the liver as age increased. The expression levels of total CYP3A protein and total CYP3A mRNA showed good correlation. Despite apparent regulation of CYP3A4 mRNA expression by estrogen, the effects of estrogen may be overshadowed by additional regulators of gene expression.
引用
收藏
页码:728 / 735
页数:8
相关论文
共 50 条
  • [1] Cytochrome P450 3A and their regulation
    Burk, O
    Wojnowski, L
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) : 105 - 124
  • [2] Cytochrome P450 3A and their regulation
    Oliver Burk
    Leszek Wojnowski
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 369 : 105 - 124
  • [3] REGULATION OF 2 MEMBERS OF THE STEROID-INDUCIBLE CYTOCHROME P450 SUBFAMILY (3A) IN RATS
    COOPER, KO
    REIK, LM
    JAYYOSI, Z
    BANDIERA, S
    KELLEY, M
    RYAN, DE
    DANIEL, R
    MCCLUSKEY, SA
    LEVIN, W
    THOMAS, PE
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 301 (02) : 345 - 354
  • [4] Risperidone and cytochrome P450 3A
    deLeon, J
    Bork, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (10) : 450 - 450
  • [5] Comparison of Cytochrome P450 3A Enzymes in Cynomolgus Monkeys and Humans
    Iwasaki, Kazuhide
    Murayama, Norie
    Koizumi, Ryo
    Uno, Yasuhiro
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2010, 25 (04) : 388 - 391
  • [6] Bimodal distribution of renal cytochrome P450 3A activity in humans
    Haehner, BD
    Gorski, JC
    Vandenbranden, M
    Wrighton, SA
    Janardan, SK
    Watkins, PB
    Hall, SD
    MOLECULAR PHARMACOLOGY, 1996, 50 (01) : 52 - 59
  • [7] α-hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes
    Kim, SY
    Suzuki, N
    Laxmi, YRS
    Rieger, R
    Shibutani, S
    CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (09) : 1138 - 1144
  • [8] Porcine cytochrome P450 3A: current status on expression and regulation
    Rasmussen, Martin Kroyer
    ARCHIVES OF TOXICOLOGY, 2020, 94 (06) : 1899 - 1914
  • [9] Porcine cytochrome P450 3A: current status on expression and regulation
    Martin Krøyer Rasmussen
    Archives of Toxicology, 2020, 94 : 1899 - 1914
  • [10] Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans
    Okudaira, Toshiaki
    Kotegawa, Tsutomu
    Imai, Hiromitsu
    Tsutsumi, Kimiko
    Nakano, Shigeyuki
    Ohashi, Kyoichi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (07): : 871 - 876